MOLECURE

Research MOLECURE (MOC.WA) on Bullrun: market cap PLN 175.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMOC.WA
ExchangeXWAR
CountryPoland
SectorHealthcare
IndustryBiotechnology
CurrencyPLN
Market capPLN 175.04M
Financial periodQ1 2025
RevenuePLN 0
Net income-PLN 5.18M
Free cash flowPLN 22.41M

Valuation Snapshot

latest market cap is PLN 175.04M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2023	PLN 3.65M	-PLN 28.37M	n/a	n/a	-1.69	PLN 63.99M	n/a	PLN 100.93M
FY2022	PLN 7.51M	-PLN 35.95M	n/a	n/a	-2.56	PLN 65.62M	n/a	PLN 80.21M
FY2021	PLN 1.17M	-PLN 13.64M	n/a	n/a	-0.98	PLN 102.04M	n/a	PLN 115.59M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-10	PLN 175.04M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 PLN.

About MOLECURE

Molecure S.A., a biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed Phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH.

Related stock research

Poland stocks Poland Healthcare stocks A-Z stock index

Other Healthcare stocks

BIOCELTIX (BCX.WA) BIOTON (BIO.WA) CAPTORTX (CTX.WA) Mabion SA (MAB.WA) MULTIQURE (MQR.WA) Nanogroup SA (NNG) PHARMENA (PHR.WA) PolTREG S.A. (PTG) READGENE (RDG.WA) Ryvu Therapeutics SA (RVU) SYN2BIO SPÓŁKA AKCYJNA (S2B) STEMCELLS (SCS.WA)

Frequently asked questions

What is MOLECURE's market cap?

MOLECURE's market capitalization is PLN 175.04M.